B-cell lymphoma risk factors: Difference between revisions
Jump to navigation
Jump to search
Adnan Ezici (talk | contribs) No edit summary |
Adnan Ezici (talk | contribs) No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}} ; {{AE}} {{Adnan Ezici}} | {{CMG}} ; {{AE}} {{Adnan Ezici}} | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of B-cell lymphoma include family history, infections, obesity, drugs, environmental factors, genetic mutations, [[immunodeficiency]] states, [[autoimmune diseases]]. | Common risk factors in the development of B-cell lymphoma include family history, [[infections]], [[obesity]], drugs, environmental factors, [[genetic mutations]], [[immunodeficiency]] states, and [[autoimmune diseases]]. | ||
==Risk Factors== | ==Risk Factors== | ||
===Common Risk Factors=== | ===Common Risk Factors=== | ||
*Common risk factors in the development of [disease name] include:<ref name="pmid15803153">{{cite journal |vauthors=Küppers R |title=Mechanisms of B-cell lymphoma pathogenesis |journal=Nat Rev Cancer |volume=5 |issue=4 |pages=251–62 |date=April 2005 |pmid=15803153 |doi=10.1038/nrc1589 |url=}}</ref><ref name="pmid32644754">{{cite journal |vauthors=Sapkota S, Shaikh H |title= |journal= |volume= |issue= |pages= |date= |pmid=32644754 |doi= |url=}}</ref><ref name="pmid32809661">{{cite journal |vauthors=Jamil A, Mukkamalla SKR |title= |journal= |volume= |issue= |pages= |date= |pmid=32809661 |doi= |url=}}</ref><ref name="pmid26744436">{{cite journal |vauthors=Flowers CR, Skibola CF |title=Identifying risk factors for B-cell lymphoma |journal=Blood |volume=127 |issue=1 |pages=10–1 |date=January 2016 |pmid=26744436 |pmc=4705601 |doi=10.1182/blood-2015-11-677203 |url=}}</ref> | *Common risk factors in the development of [disease name] include:<ref name="pmid15803153">{{cite journal |vauthors=Küppers R |title=Mechanisms of B-cell lymphoma pathogenesis |journal=Nat Rev Cancer |volume=5 |issue=4 |pages=251–62 |date=April 2005 |pmid=15803153 |doi=10.1038/nrc1589 |url=}}</ref><ref name="pmid32644754">{{cite journal |vauthors=Sapkota S, Shaikh H |title= |journal= |volume= |issue= |pages= |date= |pmid=32644754 |doi= |url=}}</ref><ref name="pmid32809661">{{cite journal |vauthors=Jamil A, Mukkamalla SKR |title= |journal= |volume= |issue= |pages= |date= |pmid=32809661 |doi= |url=}}</ref><ref name="pmid26744436">{{cite journal |vauthors=Flowers CR, Skibola CF |title=Identifying risk factors for B-cell lymphoma |journal=Blood |volume=127 |issue=1 |pages=10–1 |date=January 2016 |pmid=26744436 |pmc=4705601 |doi=10.1182/blood-2015-11-677203 |url=}}</ref> | ||
**First degree family history of [[non-Hodgkin lymphoma]] | **First degree family history of [[non-Hodgkin lymphoma]] | ||
**Infections such as [[Epstein Barr virus]] (EBV), [[HTLV-1]], [[Kaposi's sarcoma-associated herpesvirus|HHV8]], [[Hepatitis C|Hepatitis C virus]], [[Helicobacter pylori]], [[Coxiella burnetii]] | **Infections such as [[Epstein Barr virus]] (EBV), [[HTLV-1]], [[Kaposi's sarcoma-associated herpesvirus|HHV8]], [[Hepatitis C|Hepatitis C virus]], [[Helicobacter pylori]], and [[Coxiella burnetii]] | ||
**[[Obesity]] (BMI≥30 kg/m2) in young patients | **[[Obesity]] (BMI≥30 kg/m2) in young patients | ||
**Drugs such as [[phenytoin]], [[digoxin]], TNF-a antagonist | **Drugs such as [[phenytoin]], [[digoxin]], and TNF-a antagonist | ||
**Environmental factors such as pesticides, solvents, organic chemicals, radiation exposure, etc. | **Environmental factors such as pesticides, solvents, organic chemicals, radiation exposure, etc. | ||
**[[B-cell lymphoma pathophysiology|Genetic mutations]] | **[[B-cell lymphoma pathophysiology|Genetic mutations]] | ||
Latest revision as of 19:27, 22 February 2022
|
B-cell lymphoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
B-cell lymphoma risk factors On the Web |
|
American Roentgen Ray Society Images of B-cell lymphoma risk factors |
|
Risk calculators and risk factors for B-cell lymphoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]
Overview
Common risk factors in the development of B-cell lymphoma include family history, infections, obesity, drugs, environmental factors, genetic mutations, immunodeficiency states, and autoimmune diseases.
Risk Factors
Common Risk Factors
- Common risk factors in the development of [disease name] include:[1][2][3][4]
- First degree family history of non-Hodgkin lymphoma
- Infections such as Epstein Barr virus (EBV), HTLV-1, HHV8, Hepatitis C virus, Helicobacter pylori, and Coxiella burnetii
- Obesity (BMI≥30 kg/m2) in young patients
- Drugs such as phenytoin, digoxin, and TNF-a antagonist
- Environmental factors such as pesticides, solvents, organic chemicals, radiation exposure, etc.
- Genetic mutations
- Immunodeficiency states such as severe combined immunodeficiency, Wiskott-Aldrich syndrome, AIDS, and immunosuppressive therapy
- Autoimmune diseases such as rheumatoid arthritis, Sjögren's syndrome, celiac disease, and Hashimoto's thyroiditis
References
- ↑ Küppers R (April 2005). "Mechanisms of B-cell lymphoma pathogenesis". Nat Rev Cancer. 5 (4): 251–62. doi:10.1038/nrc1589. PMID 15803153.
- ↑ Sapkota S, Shaikh H. PMID 32644754 Check
|pmid=value (help). Missing or empty|title=(help) - ↑ Jamil A, Mukkamalla S. PMID 32809661 Check
|pmid=value (help). Vancouver style error: initials (help); Missing or empty|title=(help) - ↑ Flowers CR, Skibola CF (January 2016). "Identifying risk factors for B-cell lymphoma". Blood. 127 (1): 10–1. doi:10.1182/blood-2015-11-677203. PMC 4705601. PMID 26744436.